Concepedia

William Burgan

WB

Statistics

Publications

25

Citations

2.4K

H-Index

24

Active since

2003

Affiliations

National Cancer Institute(Current)

Science Applications International Corporation (United States)

Molecular Oncology (United States)

Moffitt Cancer Center

Frederick National Laboratory for Cancer Research

William Burgan is an author at National Cancer Institute specializing in tumor biology, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2022

25

Publications

25

Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers

Suman Mukhopadhyay, Debanjan Goswami, Pavan P. Adiseshaiah et al. · Cancer Research · 2020 · 304 citations · Full text

Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275

Kevin Camphausen, William Burgan, Michael Cerra et al. · Cancer Research · 2004 · 211 citations

Enhancement of <i>in vitro</i> and <i>in vivo</i> tumor cell radiosensitivity by valproic acid

Kevin Camphausen, David Cerna, Tamalee Scott et al. · International Journal of Cancer · 2004 · 191 citations · Full text

, , +18

<i>In vitro</i> and <i>In vivo</i> Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

Andrea Russo, Hyuk‐Chan Kwon, William Burgan et al. · Clinical Cancer Research · 2009 · 165 citations · Full text

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

Jeffery S. Russell, Kristin J. Brady, William Burgan et al. · PubMed · 2003 · 161 citations

, , +17

1–5 of 25